dermapharm limited
dermapharm limited Company Information
Company Number
03480801
Next Accounts
Sep 2025
Directors
Shareholders
alliance pharmaceuticals ltd
Group Structure
View All
Industry
Dormant Company
Registered Address
avonbridge house, bath road, chippenham, wiltshire, SN15 2BB
Website
http://alliancepharma.co.ukdermapharm limited Estimated Valuation
Pomanda estimates the enterprise value of DERMAPHARM LIMITED at £0 based on a Turnover of £0 and 0x industry multiple (adjusted for size and gross margin).
dermapharm limited Estimated Valuation
Pomanda estimates the enterprise value of DERMAPHARM LIMITED at £0 based on an EBITDA of £0 and a 1.92x industry multiple (adjusted for size and gross margin).
dermapharm limited Estimated Valuation
Pomanda estimates the enterprise value of DERMAPHARM LIMITED at £0 based on Net Assets of £-41.7k and 0.54x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dermapharm Limited Overview
Dermapharm Limited is a live company located in chippenham, SN15 2BB with a Companies House number of 03480801. It operates in the dormant company sector, SIC Code 99999. Founded in December 1997, it's largest shareholder is alliance pharmaceuticals ltd with a 100% stake. Dermapharm Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dermapharm Limited Health Check
There is insufficient data available to calculate a health check for Dermapharm Limited. Company Health Check FAQs
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Dermapharm Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Dermapharm Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Dermapharm Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Dermapharm Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 127.9%, this is a higher level of debt than the average (71.4%)
- - Dermapharm Limited
- - Industry AVG
DERMAPHARM LIMITED financials
Dermapharm Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of -£41.7 thousand. According to their latest financial statements, we estimate that Dermapharm Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | 149,791 | 149,791 | 149,791 | 149,791 | 149,791 | ||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 149,791 | 149,791 | 149,791 | 149,791 | 149,791 | ||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | |||||||||||||||
| Cash | |||||||||||||||
| misc current assets | |||||||||||||||
| total current assets | |||||||||||||||
| total assets | 149,791 | 149,791 | 149,791 | 149,791 | 149,791 | ||||||||||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | 191,515 | 191,515 | 191,515 | 191,515 | 191,515 | ||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | |||||||||||||||
| total current liabilities | 191,515 | 191,515 | 191,515 | 191,515 | 191,515 | ||||||||||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 191,515 | 191,515 | 191,515 | 191,515 | 191,515 | ||||||||||
| net assets | -41,724 | -41,724 | -41,724 | -41,724 | -41,724 | ||||||||||
| total shareholders funds | -41,724 | -41,724 | -41,724 | -41,724 | -41,724 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | |||||||||||||||
| Creditors | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 191,515 | ||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | |||||||||||||||
| change in cash |
dermapharm limited Credit Report and Business Information
Dermapharm Limited Competitor Analysis
Perform a competitor analysis for dermapharm limited by selecting its closest rivals, whether from the ACTIVITIES OF EXTRATERRITORIAL ORGANISATIONS AND BODIES sector, other mature companies, companies in SN15 area or any other competitors across 12 key performance metrics.
dermapharm limited Ownership
DERMAPHARM LIMITED group structure
Dermapharm Limited has no subsidiary companies.
Ultimate parent company
2 parents
DERMAPHARM LIMITED
03480801
dermapharm limited directors
Dermapharm Limited currently has 1 director, Mr Andrew Franklin serving since Sep 2015.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Andrew Franklin | United Kingdom | 58 years | Sep 2015 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-41.7k
0%
total assets
149.8k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
dermapharm limited company details
company number
03480801
Type
Private limited with Share Capital
industry
99999 - Dormant Company
incorporation date
December 1997
age
28
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
avonbridge house, bath road, chippenham, wiltshire, SN15 2BB
Bank
-
Legal Advisor
-
dermapharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dermapharm limited.
dermapharm limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DERMAPHARM LIMITED. This can take several minutes, an email will notify you when this has completed.
dermapharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
